Immucell's market cap is currently $43.42M. The company's EPS TTM is $-0.015; its P/E ratio is 18.54; Immucell is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
